Kathy L Hibbs
First SEC filing: March 18, 2026 · Latest: March 18, 2026
Insider at
Insider transactions
Price change vs the latest weekly close (updated to the current quote in your browser when available), split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 8, 2026 | SOPH | S 10b5-1 | 6,250 | $8.13 | $50,812 | 96,992 Direct | -6.05% | Disposed | -9.6% (price as of ) |
| Aug. 25, 2026 | SOPH | S 10b5-1 | 6,250 | $8.68 | $54,250 | 103,242 Direct | -5.71% | Disposed | -15.3% (price as of ) |
| June 18, 2026 | LAB | A | 99,116 | · | · | 236,836 Direct | +71.97% | Acquired | |
| June 18, 2026 | LAB | A | 175,923 | · | · | 175,923 Direct | · | Acquired | |
| June 18, 2026 | SOPH | A | 19,724 | $5.46 | $107,693 | 109,492 Direct | +21.97% | Acquired | 34.6% (price as of ) |
| June 18, 2026 | SOPH | A | 28,818 | $5.46 | $157,346 | 218,569 Direct | +15.19% | Acquired | |
| May 12, 2026 | SOPH | S 10b5-1 | 7,508 | $4.67 | $35,062 | 89,768 Direct | -7.72% | Disposed | 57.4% (price as of ) |
| June 20, 2025 | LAB | A | 94,592 | · | · | 137,720 Direct | +219.33% | Acquired | |
| June 20, 2025 | LAB | A | 125,660 | · | · | 125,660 Direct | · | Acquired | |
| June 28, 2024 | LAB | A | 43,128 | · | · | 43,128 Direct | · | Acquired | |
| June 28, 2024 | LAB | A | 72,213 | · | · | 72,213 Direct | · | Acquired | |
| Jan. 5, 2024 | LAB | A | 79,412 | · | · | 79,412 Direct | · | Acquired | |
| Jan. 5, 2024 | LAB | A | 205,794 | · | · | 205,794 Direct | · | Acquired |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 18, 2026 | LAB | Stock Option (Right to buy) | Common Stock | $0.83 | June 18, 2036 | 175,923 | Acquired |
| June 18, 2026 | SOPH | Share Option (Right to Buy) | Ordinary Shares | $5.46 | June 18, 2036 | 28,818 | Acquired |
| June 20, 2025 | LAB | Stock Option (Right to buy) | Common Stock | $1.05 | June 20, 2035 | 125,660 | Acquired |
| June 28, 2024 | LAB | Stock Option (Right to buy) | Common Stock | $1.77 | June 28, 2034 | 72,213 | Acquired |
| Jan. 5, 2024 | LAB | Stock Option (Right to buy) | Common Stock | $2.47 | June 7, 2033 | 205,794 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.